Leonteq Securities AG’s Amicus Therapeutics FOLD Stock Holding History

Leonteq Securities AG’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,404	Closed	-$34.8K	–	1318
2026 Q1	$34.8K	Sell	2,404 -353	-13%	-$5.06K	﹤0.01%	912
2025 Q4	$39.3K	Sell	2,757 -10,489	-79%	-$103K	﹤0.01%	993
2025 Q3	$104K	Sell	13,246 -10,157	-43%	-$72.3K	﹤0.01%	737
2025 Q2	$134K	Buy	23,403 +13,037	+126%	+$84.1K	0.01%	652
2025 Q1	$84.6K	Buy	10,366 +1,242	+14%	+$11.5K	﹤0.01%	735
2024 Q4	$85.9K	Buy	9,124 +6,432	+239%	+$66.9K	0.01%	721
2024 Q3	$28.8K	Buy	+2,692	New	+$29.3K	﹤0.01%	862

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Leonteq Securities AG's FOLD Position: Q2 2026 in Review

Leonteq Securities AG sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 2,404 shares — an estimated $34.8K sold.

Leonteq Securities AG first reported a position in FOLD in Q3 2024 and held it in 7 quarters. The position peaked at $134K in Q2 2025. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Leonteq Securities AG reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Leonteq Securities AG sold 2,404 Amicus Therapeutics shares in Q2 2026, an estimated $34.8K.
Leonteq Securities AG first reported a position in Amicus Therapeutics in Q3 2024 and held it in 7 quarters.
Leonteq Securities AG's Amicus Therapeutics position peaked at $134K in Q2 2025.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.